Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00228-012-1251-4.pdf
Reference68 articles.
1. Schmiegelow K, Schrøder H, Gustafsson G et al (1995) Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. J Clin Oncol 13(2):345–351
2. Elion GB, Hitchings GH, Vanderwerff H (1951) Antagonists of nucleic acid derivatives. VI. Purines. J Biol Chem 192(2):505–518
3. Adam de Beaumais T, Fakhoury M, Medard Y et al (2011) Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Br J Clin Pharmacol 71(4):575–584
4. McLeod HL, Krynetski EY, Relling MV, Evans WE (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14(4):567–572
5. Fakhoury M, de Beaumais T, Médard Y, Jacqz-Aigrain E (2010) Therapeutic drug monitoring of 6-thioguanine nucleotides in paediatric acute lymphoblastic leukaemia: interest and limits. Therapie 65(3):187–193
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular docking and DFT study of antiproliferative ribofuranose nucleoside derivatives targeting EGFR and VEGFR2in cancer cells;Computational Biology and Chemistry;2024-12
2. Use of allopurinol to manage skewed 6‐mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatment;European Journal of Haematology;2024-07-11
3. Importance of pharmacologic considerations in the development of targeted anticancer agents for children;Current Opinion in Pediatrics;2022-12-23
4. Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis;Pharmaceuticals;2022-03-29
5. Purine-based anticancer drugs;New Strategies Targeting Cancer Metabolism;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3